Thromboprophylaxis in lung cancer patients with intermediate tinzaparin dose: The iCaLT study

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.